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Tuberculosis, a List B disease of World Organization for Animal Health, caused by M. avium or M. genavense predominantly
aﬀects poultry and pet or captive birds. Clinical manifestations in birds include emaciation, depression and diarrhea along with
marked atrophy of breast muscle. Unlike tuberculosis in animals and man, lesions in lungs are rare. Tubercular nodules can be
seen in liver, spleen, intestine and bone marrow. Granulomatous lesion without calciﬁcation is a prominent feature. The disease
is a rarity in organized poultry sector due to improved farm practices, but occurs in zoo aviaries. Molecular techniques like
polymerase chain reaction combined with restriction fragment length polymorphism and gene probes aid in rapid identiﬁcation
and characterization of mycobacteria subspecies, and overcome disadvantages of conventional methods which are slow, labour
intensive and may at times fail to produce precise results. M. avium subsp. avium with genotype IS901+a n dIS1245+c a u s e s
infections in animals and human beings too. The bacterium causes sensitivity in cattle to the tuberculin test. The paper discusses
in brief the M. avium infection in birds, its importance in a zoonotic perspective, and outlines conventional and novel strategies
for its diagnosis, prevention and eradication in domestic/pet birds and humans alike.
1.Introduction
Avian tuberculosis is one of the most important diseases
that aﬀect domestic and pet birds. Several mycobacterial
species can be involved in the aetiology of avian tuberculosis.
The disease is most often caused by Mycobacterium avium
belonging to serotypes 1, 2, 3, and 6 (genotype IS901+ and
IS1245+)a n dM. genavense [1–3]. Other species, such as M.
intracellulare, M. scrofulaceum, M. fortuitum, M. tuberculosis,
and M. bovis can also cause avian tuberculosis, but the
incidences are rare [2, 4–6]. M. avium causes avian tuber-
culosis in probably all avian species, especially in waterfowl,
galliformes, columbiformes, passerines, psittacines, raptors,
and ratites [1, 7–10]. The disease has a worldwide distri-
b u t i o nb u ti ss e e nm o s tf r e q u e n t l yi nt h eN o r t hT e m p e r a t e
Zone [11–14]. Susceptibility to disease varies from species
to species. Hejlicek and Treml [15] broadly classiﬁed bird
species into four groups according to their susceptibility to
avian tuberculosis as highly susceptible: domestic fowl, spar-
rows, pheasants, and partridges; less susceptible: guinea fowl
and domestic turkeys; moderately resistant: domestic goose
and duck, highly resistant: the domestic pigeon. In any avian
species, stress factors appear to enhance the development of
thediseaseandthisisparticularlynoteworthyincaseofbirds
living in captivity [4]. Infected birds and contaminated water
and soil are the main source of infection as the Mycobacteria
can survive for several months in the environment [2, 5].
The disease is more prevalent in places with high population
density and poor sanitation and hygienic conditions. The
practices of allowing birds to roam freely and keeping the2 Veterinary Medicine International
breeders for several years are highly conducive to the spread
oftuberculosis[11].Inaﬂockifonceestablished,TBinduces
unthriftiness, decreased egg production, and increased mor-
tality, which culminates into severe economical losses.
Mycobacterium avium complex (MAC), comprising M.
avium subsp. avium, M. avium subsp. paratuberculosis, M.
avium subsp. Silvaticum, and M. intracellulare, may also
infect diﬀerent animal species like swine, cattle, deer, sheep,
goat, horses, cats, dogs, and exotic species besides causing
infection in immunocompromised human beings [3, 4, 16,
17]. M. genavense has also been reported in a dog and
an immunocompromised cat. M. intracellulare is a closely
related pathogen of birds with a lower prevalence [18].
Although successful experimental infections with M. a.
paratuberculosisinpoultryhavebeenreported[19],however,
this subspecies, known to cause Johne’s disease (paratuber-
culosis) in ruminants and other mammals, has not been
encountered during any of the cases of avian tuberculosis till
date.M.aviumsubsp.avium(MAA)isconsideredasthemost
important pathogen causing tuberculosis in domestic birds
[2, 20]. On the basis of genetic and phenotypic diﬀerences
it has been proposed to categorize MAA into two subspecies,
namely,M.a.hominissuisforhumanandporcineisolatesand
M. a. avium for bird-type isolates [21]. In humans, M. avium
is capable of inducing a progressive disease that is refractory
toantibiotictreatmentandisrecognizedaslocalizedprimary
lymphadenitis, pulmonary disease, and a disseminated form
of infection [4, 22]. Hence the handling of infected birds in
farms or live cultures of M. avium in laboratories should be
c a r r i e do u tw i t ha d e q u a t ec a r e .
2.Etiology
M. avium, the causative agent of avian tuberculosis,
considered as “atypical mycobacteria”, comprises aerobic,
nonspore-forming and nonmotile rod shaped bacteria that
vary in length from 1–3μm and cords are not formed,
unlike M. tuberculosis [2]. They are weakly Gram-positive
and stained speciﬁcally by acid fast (Ziehl-Neelsen) staining
method, due to high levels of lipids in mycobacterial cell
wall.M.aviumishighlyresistanttoenvironmentalchallenges
and can survive in soil for up to 4 years, and this makes
eradication of the organism diﬃcult [1, 2, 23]. M. avium
is resistant to high and low temperatures, dryness, pH
changes, and many commonly used disinfectants. However,
the unprotected organism is killed by direct sunlight. In
contrast to M. tuberculosis and M. bovis, M. avium grows
at temperatures ranging from 25–45◦C, the most favorable
range being 29–45◦C and for primary isolation, growth can
be enhanced with 5–10% CO2 tension [3, 23]. Strains of
M. avium can be identiﬁed by serological procedures. To
date, 28 MAC serotypes have been identiﬁed from which
the serotypes 1–6, 8–11, and 21 belong to M. avium subsp.
avium (MAA). Serovars 7, 12–20, and 25 have been ascribed
to M. intracellulare. However, no consensus was achieved
on other serovars, and some isolates cannot be typed [3,
24]. Serotypes 1, 2, and 3 are considered virulent for
chickens (Table 1)[ 2, 11, 23]. Serotypes 1 and 2 are most
commonly isolated from domestic birds, and serovar 3 is
Table 1: Serotypes of M. avium complex (MAC) and their
susceptibilitytovariousspeciesofcertainbirdsandmammals[2,9].
Species MAC
serotypes Susceptibility
Domestic fowl
(Gallus domesticus) 1, 2 High
Turkey 1, 2 Moderate
Pheasants 1, 2 High
Wild birds 2, 3 High
Cattle 1, 2 Moderate
Swine 1, 2, 4, 8 High
Rabbit 1, 2 High
Man 1, 4 to 20;
23, 25
Low (in healthy individuals);
High (in immunocompromised)
recovered sporadically from wild birds. Serotypes 1 and 2 can
aﬀect animals, whereas 4–20 are mainly found in humans.
Serovar-1 is the most common organism isolated from birds
and from human beings. Distinguishing serovars can help
provide a means for studying origin and distribution of
speciﬁc strains. According to the current taxonomy, M.
avium contains four subspecies, namely, M. avium subsp.
avium;M.avium.hominissuis;M.avium.Paratuberculosis;M.
avium. silvaticum, which is diagnosed rarely in birds [3, 21].
It is well established that most M. a. avium isolates from
birds have a repetitive sequence IS901 in their genome and
also produce a characteristic three band pattern in IS1245
restriction fragment length polymorphism (RFLP) [25]. It
hasbeenpostulatedthatthepresenceofIS901correlates with
pathogenicity in birds [25–27]. Other than M. a. silvaticum,
IS901 has only been detected in M. avium strains with
s e r o t y p e s1 ,2 ,a n d3[ 5].
M. avium is the most signiﬁcant cause of poultry disease.
Disease onset in birds is normally more rapid with M.
genavense than with M. avium. In wild birds, though the
disease is uncommon, TB may develop when they are
in contact with infected chickens. Mycobacterium avium
complex and M. intracellulare can also infect an extensive
range of diﬀerent animal species. M. tuberculosis is less
commonly the cause of infection in birds, often as a result
of transmission from pet bird owners, and also clinical signs
diﬀer from those caused by the more commonly occurring
species of mycobacteria. In case of psittacine birds, apart
from this, tuberculosis due to M. tuberculosis or M. bovis has
also been reported. In canaries, tuberculosis may be caused
frequently by M. tuberculosis [2].
3. Transmission
The main source of infection is infected birds as they shed
large amounts of organism into the environment. The bacilli
are exuded from ulcerated lesions of the intestine and are
voided in droppings. The most common route of infection
forsusceptiblebirdsisthealimentarytract[1,2].Respiratory
tract is also suggested as a potential source of infection.
The disease gets transmitted to the susceptible birds by
ingestion and inhalation of aerosolized infectious organisms.Veterinary Medicine International 3
Persistence within ﬂocks is associated with keeping older
stocks without following adequate cleanliness and hygiene
[2]. Further, maintaining birds closely conﬁned under
stressful conditions provide favorable ways for the spread
of the disease. The ability of the organism to persist in
the environment for many years, especially in soil and
litter favor the disease transmission to a great extent [5].
Litter, pens, equipment, and pasture contaminated with
excreta of infected domestic birds and the hands, feet, and
clothing of attendants play an important role in disease
transmission. Wild birds, pigs, and some mammals may
also act as signiﬁcant reservoirs of infection [2, 11]. Wild
birds, such as sparrows, crows, and pigeons may be infected
with M. avium and may spread it to poultry ﬂocks [7].
Also, rats and other rodents are known to act as mechanical
carriers in transmission of the disease. The agent can also be
disseminated by infected carcasses and oﬀals. Occasionally,
skin invasion and spread via infected eggs may occur. M.
avium has been isolated from eggs of naturally infected
chickens, but hatched chicks have not developed the disease
[2]. The bacilli does not survive in eggs after proper boiling.
4. The Disease andManifestations
Avian tuberculosis is a contagious disease which occurs in
chickens, pheasants, quail, guinea fowl, turkeys, parrots,
budgerigars, ducks, goose, doves, partridges, pigeons, and
othercaptive andwildgamebirds andhasalsobeen reported
in ostriches, emus, and rheas in many zoological parks.
Tuberculosis in birds is most prevalent in chickens and in
wild birds raised in captivity. In poultry, the disease follows
a slow course through the ﬂocks. The classical presentation
is characterised by chronic and progressive wasting and
weakness. Avian tuberculosis in domestic birds is primarily
an intestinal and hepatic disease with dissemination to other
organs including the lungs, air sacs, spleen, bone marrow,
and skin [2, 6, 11, 23]. Similarly, avian tuberculosis reported
in free living birds including raptors were presented with
the disseminated form involving the digestive tract, liver and
spleen [8, 28, 29]. The disease has a long incubation period
and a protracted course and if appreciable, the symptoms
can prolong for weeks or months. Because of the chances to
become established through a longer exposure, the disease
is less prevalent in young fowls and lesions are less severe
in them when compared to adult birds. Usually the losses
are experienced more in older stocks of age group 18–20
months.Thediseaseprocesscanbedividedintothreephases:
latency,lesiondevelopment,andperiodofcachexia[2,5,11].
During cachexia, massive tubercles with large numbers of
bacilli develop. In the classic form of infection the tubercles
or granulomas develop in multiple organs; a second form
is manifested with lesions in the intestinal tract; a third
type of infection often experienced as a nontuberculous one,
mainly seen in ﬁnches, canaries, and psittacines [2, 5]. Some
birds show respiratory signs and sudden death may occur,
dyspnoea is less common, and granulomatous ocular lesions
[30] and skin lesions have been reported.
Clinical signs are not pathognomonic in avian TB and
vary depending on the organs involved. Birds with the
intestinal form of tuberculosis often present with chronic
wasting disease. In majority of cases of tuberculosis in birds,
especially in the initial phase of infection, clinical signs are
not grossly observable. However, in advanced cases, birds
may develop symptoms like progressive weight loss, depres-
sion, white diarrhea with soiled feathers, increased thirst,
respiratory distress, fatigue, and decreased egg production
[11, 23, 31–33]. Feathers are often dull or ruﬄed and comb,
wattle, and earlobes often appear pale, thinner and dry. Birds
eventually become lethargic and emaciated with marked
atrophy of breast muscles manifested as “knife edged” keel
[2, 5]. In extreme cases, the body fat disappears, and the face
of the bird appears smaller than normal. If a jerky hopping
gait is observed due to unilateral lameness then it should
be assumed that there could be the presence of tubercular
lesions in bone marrow of the leg bones or joints. Some birds
may adapt a sitting position. Tuberculous arthritis can even
lead to paralysis. Fatal results often occur due to massive
hemorrhage caused by ruptured liver or spleen. In this case,
occasionallybirdsmaydiesuddenlyingoodbodilycondition
and yet show advanced lesions of tuberculosis. The body
temperature of the aﬀected bird remains normal, even in
severe cases. In most cases, an infected bird without overt
clinicalsignsmayserveascarrierthatresultinthepersistence
of infection in ﬂocks. In commercial broiler production
units, generally avian tuberculosis is uncommon primarily
due to the short life span and in layers and breeders, the
infection is a matter of much concern. Mortality over a
short period may be insigniﬁcant, but the intermittent loss
of adult birds in valuable breeding stock and decreased egg
production in layers are detrimental. Occasionally, heavy
losses may occur in pullets on multiage sites where the
infection is endemic and the hygienic standards are poor.
After entering the host, M. avium prevents the fusion of
phagosomes with lysosome and the subsequent bacteremia
provides a generalized distribution of lesion. The gross
lesions are characterized by the presence of epithelioid cells
containing large numbers of organisms that may either
diﬀuselyinﬁltratetheorganorformdiscretegranulomas[6].
There is presence of tubercular nodules in intestine, liver,
spleen, ovaries, testes, and bone marrow but the pulmonary
lesions, which are a striking feature of tuberculosis in other
species, are rarely observed in birds [2, 5]. Pulmonary avian
tuberculosis is only seen occasionally as in case of tubercu-
losis of pigeons and water fowl [1, 2]. The principal lesions
of tuberculosis in birds are seen in intestine, where aﬀection
often presents with studded greyish-white to greyish-yellow
nodules. Before the intestinal tract is opened, the ulcerated
areas appear as tumour-like masses attached to the gut wall,
but when the intestine is opened, the true nature of the
mass becomes evident. The nodules bulge from the serosal
surface of the intestine and can be palpated. Due to this,
spleen takes irregular “knobbly” appearance. Lesions evident
as deep ulcers ﬁlled with caseous material discharges the
organism into the intestinal lumen and get excreted via
the droppings. Typical caseous lesions, without calciﬁcation,
are always found in the liver and spleen, with considerable
enlargement of the organs [2, 5]. Nodules are ﬁrm but can be
incised easily since mineralization is rare in avian TB (this is4 Veterinary Medicine International
Figure 1: Spleen of Demoiselle cranes (Anthropoides virgo) show-
ing caseous nodules, measuring 1–5mm in size, on the cut surfaces
of the organ.
Figure 2: Section of spleen showing a granuloma with associated
inﬂammatory cells, H&E × 120.
in contrast to leucosis, in which lesions cannot be enucleated
from the surrounding tissue). The bone marrow of the long
bones frequently contains tubercular nodules. Some exotic
bird species may have lesions in the liver and spleen without
intestinal involvement. Microscopically, lesions consist of
granulomas with a central necrosis, either coagulative or
caseous, and multinucleate giant cells. Acid fast bacilli are
numerous in the central or necrotic zone of the tubercle [2,
11]. Gross and microscopic lesions in spleen of Demoiselle
cranes (Anthropoides virgo) are depicted in Figures 1 and 2.
The incidence of avian tuberculosis in pet birds kept in
captivityappearstoexceedtheprevalenceinpoultry[22,34].
Some of the reasons of the incidence of the infection in
pet birds are age of the host, population density, and the
ability of organism to survive environmental inclemency [2].
Contact with contaminated water, soil, or feed predisposes
to infection [22]. In case of pet birds, the etiology of
avian tuberculosis is rarely identiﬁed due to the diﬃculty
in isolating some mycobacterial species [23]. Weight loss,
diarrhea, dyspnea, lameness, and poor feathering are the
usual signs in pet birds. Earlier, most cases of infection were
assumed to be caused by Mycobacterium avium complex
(MAC). However, the use of molecular techniques brought
to light the prominent role of fastidious mycobacteria,
primarily M. genavense, in avian tuberculosis of pet birds
[22]. M genavense is responsible for the majority of avian
mycobacterial infections (up to 80%) in pet birds while the
MAC was found responsible for 5% to 10% of mycobacterial
infections [22]. In pet birds, M. genavense causes a dissem-
inated disease with clinical and histopathological features
indistinguishable from infection caused by members of the
MAC [34].
Recently, avian tuberculosis in domestic poultry have
declined due to changes in poultry husbandry practices,
namely, integrated poultry farming, emphasizing all-pullet
ﬂocks rather than older hens and maintaining one-age
ﬂocks, all in all out farming system, along with better
hygiene,disinfection,andbiosecuritypractices.However,the
occurrence of avian TB in birds in zoo aviaries is still an
economically important aﬀair since certain species of exotic
birds are of high value and most of these birds will be in
endangered or near extinction categories. Avian TB is more
common in zoological parks, perhaps because of inadequate
cleaning and disinfection of pens. Caged birds are reported
to soon succumb to avian TB.
M. avium can infect and cause disease in some domes-
ticated mammals but lesions usually are localized and less
severe. It multiplies in tissue for a considerable period and
induces sensitivity to tuberculin. Swine, rabbit, and mink are
readily infected; infection has been reported in cattle and
horse; monkey is also susceptible; while goat, guinea pig, rat,
and mouse are relatively resistant to infection, cat and dog
are highly resistant to M. avium infection [16, 17].
5. Infection and Immunity
The cellular arm of the immune system is more impor-
tant than the humoral arm in preventing and controlling
mycobacterial infections [2, 5]. Delayed type of hyper-
sensitivity (DTH), judged by the thickness of wattle, is
evident at 2 days after infection and increases as the disease
progresses. The organism after entry when phagocytosed by
nonactivated macrophages is able to downregulate its killing
mechanism by preventing normal fusion of the phagosome
with lysosomes. Macrophages that lack microbicidal com-
ponents are destroyed by the intracellular growth of the
organism, and a lesion develops. Also, during infections,
thymus is consistently colonized by M. avium and as the
T-cell diﬀerentiation depends on the antigens encountered
within the thymus, infection of this organ can alter the
immuneresponsetoinfection[35].However,ifactivated,the
macrophages can readily destroy and degrade phagocytosed
mycobacteria [11, 36]. They have usually good killing
potential against the invading mycobacterial species [37, 38].
This is augmented by the release of lymphokines like tumor
necrosis factor (TNF) and interleukin-2 (IL-2), which helps
inkillingM.avium.Macrophageactivationisalsoperformed
byinterferongamma(IFN-γ),whichisreleasedbyasubsetof
CD4+ T lymphocytes and natural killer (NK) cells on stimu-
lation by the interleukins released by the macrophage during
its encounter with the mycobacteria. The Tlymphocytes also
stimulatesBcellstoproduceantibodiesagainstmycobacteria
buttheseantibodies donotappeartohaveamajorprotectiveVeterinary Medicine International 5
eﬀect for the host against infection and high antibody titers
canbecorrelatedwithseriousinfections[6,36,39].Recently,
it has been identiﬁed that lipoarabinomannan, an important
outer cell wall component of mycobacteria, are highly potent
nonpeptidic molecules which can be used to modulate the
host immune response [40].
6. Diagnosisof Infection
The diagnosis of M. avium infection is based on clinical
signs, postmortem gross lesions, and by demonstrating the
acid-fast bacilli in crushed lesions using microscopy, which
is suﬃcient for a positive diagnosis [2–5]. If acid-fast bacilli
are not found, but typical signs or lesions are present in
the birds, culture of the organism must be attempted. In
necropsy, liver or spleen is usually the best organ to use,
but if the carcass is decomposed, bone marrow may prove
more satisfactory as it could be less contaminated. In live
birds, cultural examination using feces or tracheal swabs
is necessary to isolate and identify the etiological agent
[23, 41]. But usually a deﬁnitive diagnosis is performed by
culturing the organism in suitable media,namely, Dorset’s
or Herrold’s egg yolk medium, Lowenstein-Jensen medium,
Middlebrook 7H10 and 7H11, or Coletsos medium, with
1% sodium pyruvate [3–5, 23]. For growth of M. avium,
media containing whole egg or egg yolk is desirable and the
incubation temperature should be 37–40◦C. Growth may be
conﬁned to the edge of the water of condensation. Cultures
should be incubated for at least 8 weeks. Typically M.
avium produces “smooth” colonies, within 2–4 weeks; rough
variants do occur; smooth transparent colonies are virulent
for chickens while variants with smooth domed or rough
colonies are avirulent. The colonies, observed only after 10–
21 days of incubation, are small, slightly raised, discrete,
and grayish white in appearance [2, 11]. Colonies are larger
if the medium contains glycerin. Shorter incubation times
can be achieved using the liquid culture BACTEC system.
SomestrainsofM.aviumhavebeenidentiﬁedtohavespecial
requirement of mycobactin as a growth factor.
Recently, comparison of the diﬀerent methods, namely,
the conventional culture method (solid Herrold’s and Stone-
brink media and liquid Sula medium) and newly developed
liquid culture systems, the manual mycobacteria growth
indicatortube(M-MGIT),andthefullyautomatedBACTEC
MGIT 960 system (A-MGIT), for the detection of M. avium
subsp. avium (MAA) in naturally infected hens revealed
overall detection rates to be 60, 70, and 76%, with the mean
time of mycobacteria detection being 32.6, 17.6, and 14.6 d,
respectively [42].
In live birds, during life time, besides the culture and iso-
lation techniques, immunological tests, namely, tuberculin
test; whole blood agglutination test and enzyme-linked
immunosorbent assay (ELISA) are also valuable diagnostic
tools; and nowadays various molecular tools are also being
employed for identiﬁcation of the causative agent at sub-
species level and epidemiological studies (Table 2). Using
standard puriﬁed protein derivative (PPD) of heat-treated
culture of M. avium,t u b e r c u l i nt e s tc a nb ep e r f o r m e di nt h e
wattle, which is considered as the test of choice in domestic
fowl/poultry. This test is less useful in other species of bird.
Birds are tested by intradermal inoculation of 0.05mL or
0.1mL tuberculin (2000IU) and the test is read after 48
hours [2]. A positive reaction is identiﬁed as a hot and
oedematous swelling at the site or by the presence of a small
ﬁrm nodule of approximately 5mm in diameter [5, 11].
It serves as a means of identifying birds infected with or
sensitized to the same species of tubercle bacillus. Tuberculin
test has 80% accuracy in detecting infective birds relative
to gross lesions but in an advanced stage of infection birds
may give no reaction. In whole blood agglutination test, a
drop of antigen (M. avium stained with 1% malachite green)
is mixed with a drop of blood and a positive reaction is
indicated by agglutination within few minutes [5, 48]. It
is a better test, especially for waterfowl. Advantage of this
test is that stock has only to be handled once, but false
positive reaction is a disadvantage which makes the test a less
speciﬁc one. The tuberculin test or the haemagglutination
(stained antigen) tests are most frequently used for export
testing of poultry. However, neither the tuberculin test nor
the agglutination test is likely to be of any value in cases
of M. tuberculosis infection in caged birds. ELISA which is
reported to be less speciﬁc than tuberculin test can detect
speciﬁc antibodies and thereby help determine exposure
to M. avium. However, false positives may be common in
ELISA. The identiﬁcation of immunogenic proteins of M.
avium may favor the development of more precise sero-
diagnostic tools [49]. Tuberculin test and serological tests are
normally used to determine the prevalence of disease in a
ﬂock, or to detect infected birds. When used to detect the
presence of tuberculosis in a ﬂock they should be supported
by the necropsy of any birds that give positive reactions.
IFN-γ assay used to diagnose human tuberculosis may also
be useful in diagnosing the infection in birds.
Species and subspecies level typing of mycobacteria
requires a specialised laboratory. Conventional biochemical
tests for species identiﬁcation are lengthy and fail to distin-
guish between M. avium and M. intracellulare. Classiﬁcation
of MAC organisms into 28 serovars has been made by
seroagglutination [3]. The MAC colonies can be identiﬁed
using high performance liquid chromatography (HPLC) for
detecting mycolic acid [4]. HPLC and use of monoclonal
antibodies to major serovars in ELISA also facilitates typ-
ing of mycobacteria. In the past decade, biotechnological
tools, exploiting nucleic acid detection methodology, like
DNA probes, polymerase chain reaction (PCR), and PCR-
restriction fragment length polymorphism (RFLP) are being
widely employed for speciﬁc detection of the etiological
agent [3, 4, 50, 51]. Commercial nucleic acid hybridisation
probes have become a “gold standard” for distinction
between M. avium, M. intracellulare, and M. genavense [2,
5, 41, 52]. For intraspecies genotyping, pulsed-ﬁeld gel elec-
trophoresis of large DNA restriction fragments has proved to
be highly sensitive [53]. The PCR approach, using species-
speciﬁc primers is also capable of speciﬁcally detecting DNA
fragments of M. avium genome, thus acting as a diagnostic
alternative to the conventional procedures [41, 54–57].
Also, a multiplex PCR method has been developed for the
determination of the subspecies within M. avium species,6 Veterinary Medicine International
Table 2: Diagnostic methods and tests used in birds [2, 3, 5, 23, 43–47].
Type of test Performed in Time
required Merits Demerits
Observing gross
lesions Dead birds 1 hour Easy diagnosis Only presumptive diagnosis
Acid fast staining Dead birds 1 hour Easy deﬁnitive diagnosis Less sensitive, Not able to
distinguish amongst species
Isolation/Culture Dead birds About 4
weeks Deﬁnitive diagnosis Time consuming
Tuberculin test Live birds 48 hours Easy to perform
Deﬁnitive diagnosis
Time consuming, Test is not very
sensitive, Possibility of false
positive and false negative results
Agglutination test Live birds Few minutes
Can diﬀerentiate serotypes. Useful
for screening large ﬂocks for
immediate culling
Occasionally false positive
reactionsNot reliable in caged
birds
ELISA Live birds 2 hours
Deﬁnitive diagnosis
Can be used for exotic and pet
birds
Less speciﬁc than tuberculin test
False positives may be there
DNA probes Bacterial cultures 4–6 hours Highly sensitive and speciﬁc
Probe may react with isolates that
genetically or biochemically do
not ﬁt within the MAC
PCR Dead/live
birds/cultures 4 hours Highly sensitive and speciﬁc Requires specialized laboratory
and trained personnel
RFLP Bacterial cultures,
clinical samples 1d a y
Diﬀerentiates mycobacteria to the
species level Discriminative for the
analysis of strain relatedness
Insuﬃcient quantities of gene
makes visualization of digested
fragments diﬃcult
Multiplex PCR
Bacterial
cultures/clinical
samples
5–8 hrs
Rapid and inexpensive technique
for subspecies identiﬁcation and
diﬀerential diagnosis of the MAC
complex
Requires specialized laboratory
Sequencing of the
16S rRNA gene Bacterial cultures 2 days Powerful technique for
diﬀerentiating species
Labor-intensive and diﬃcult to
implement in routine diagnosis
HPLC Bacterial cultures 1 day
Can identify
Mycobacteriumisolates to the
species level
Uses costly equipment and
requires substantial amounts of
the test organism.
Real-Time PCR
Bacterial
cultures/clinical
samples
4–6 h
Low risk of sample
contaminationOﬀers the
possibility to quantify bacterial
load
Sensitivity could be aﬀected by the
initial volume of DNA present
MIRU-
VNTR/MATR-
VNTR
typing
Bacterial
cultures/clinical
samples
1d a y
Improves RFLP discrimination
Useful for determination of
genotypic diversity of M. avium
subspecies
Requires specialized laboratory
Pathogenicity
tests Live young birds 5–6 weeks
Likelihood of the etiological agent
can be knownUseful in cases
where the typing facilities are not
available
Time consuming and concerned
to ethical issues
and for diﬀerentiating M. avium from M. intracellulare and
M. tuberculosis complex [56, 58, 59]. Eﬃcient diﬀerentiation
ofMACspeciesandsubspeciesbyuseofﬁve-targetmultiplex
PCR, designed to amplify a 16S rRNA gene target common
to all Mycobacterium species, has been proved to be rapid,
reliable, and simple [60]. Lappayawichit et al. [61]r e p o r t e d
the diﬀerentiation of species of mycobacteria by amplifying
16-23SribosomalDNAandfurtherdigestingwithrestriction
enzyme like Hae III, Msp I, and Bst XI.
Likewise, for diﬀerentiation of various mycobacterial
species, insertion sequences (IS) in DNA molecule have been
identiﬁed. IS 901 and IS 1245, which are virtually M. avium
speciﬁc, has been shown to be the most discriminative for
the analysis of various strains based on PCR-RFLP [1, 5, 25,
62]. Generally, the PCR-RFLP analysis of suspected tissue
samples like liver, spleen, and gonads can be performed
targeting 16S-rRNA gene for Mycobacterium spp., IS6110 for
M. tuberculosis, IS1245 for MAC, IS901 for M. avium subsp.Veterinary Medicine International 7
Avium, and hsp65 for M. genavense [34, 58, 63–66]. Utility of
PCR-RFLP of hsp65 has been reported for the identiﬁcation
of M. avium [67]. O’Grady et al. [43]p e r f o r m e dR F L P
investigation using probes derived from IS901, IS1245 and
IS1311 to study the molecular epidemiology of M. avium,
and M. intracellulare infection, in particular to gain an
understanding of the sources of infection in humans. 16S
rRNAandhsp65sequencingmayalsobeusedtodiﬀerentiate
between mycobacterial strains and for distinguishing the M.
avium subsets [68–72]. The real-time TaqMan PCR assay
targeting the hsp65 gene of M. genavense and MAC subsp.
may provide a useful tool for evaluating clinical samples for
DNA from mycobacteria species that most commonly infect
birds [44]. Slana et al. [45] has recently developed a real-time
quantitative PCR for the identiﬁcation and quantiﬁcation of
Mycobacterium avium subsp. avium and M. a. hominissuis.
Other novel tests like IFN-γ assay, GenoType assay, and DNA
microarrays that are used to diagnose human tuberculosis
may also be useful in diagnosing the infection in birds
[22, 73, 74]. More recently, the use of molecular techniques
for species identiﬁcation brought to light the prominent role
of nonculturable mycobacteria, primarily M. genavense,i n
several cases of avian tuberculosis in pet birds [5, 34].
Utilization of new variable-number tandem-repeat
markers (VNTRs) of genetic elements called mycobacterial
interspersed repetitive units (MIRUs) for typing Mycobac-
terium avium subsp. paratuberculosis and M. avium strains
has been reported to be fast typing method, and which
in combination with other methods, might prove to be
optimal for PCR-based molecular epidemiological studies
[46]. More recently, the usefulness of a MIRU-VNTR typing
has been described for determination of genotypic diversity
of M. avium subspecies (M. avium subsp. avium, M. avium
subsp. hominissuis,a n dM. avium subsp. Silvaticum)f r o m
human and animal origins [47]. Inagaki et al. [75]r e p o r t e d
MATR (Mycobacterium avium tandem repeat—MATR)-
VNTR typing method (MATR-VNTR) to be having excellent
discriminatory power compared with MIRU-VNTR and
IS1245-RFLP typing; and its concomitant use with IS1245-
RFLP typing increases the discriminatory power. MATR-
VNTR typing is inexpensive and easy to perform and thus
could be very useful for epidemiological studies.
In case the typing facilities are not available, pathogenic-
ity tests are performed for knowing the likelihood of the
etiological agent, which should be carried out on the species
of bird being investigated, but failing that, domestic fowl or
Japanese quail may be used. Young adult birds are best, and
when inoculated intravenously with 1mL of the suspension
(culture at 0.1mg/mL) the bird will die in 5–6 weeks if the
organism is virulent, or, by that time, the bird will have
extensive lesions ﬁlled with acid-fast bacilli [3].
Avian tuberculosis should be diﬀerentially diagnosed
from those diseases that are known to develop tumorous
or granulomatous lesions in gastrointestinal (GI) tract and
other visceral organs. Diseases that are to be diﬀerentially
diagnosed are pseudotuberculosis (common in ducks and
turkeys caused by Yersinia pseudotuberculosis), Coligranu-
loma (Hjarre’s disease-Escherichia coli), neoplasia due to
lymphoid leucosis (Retrovirus) or Marek’s disease (Herpes
virus),fowlcholera(Pasteurellamultocida),Pullorumdisease
(Salmonella Pullorum), and enterohepatitis (Black head,
Histomonas meleagridis)[ 9].
7. Therapy in AvianTuberculosis
Generally,mycobacteriuminfectionscausedbyM.tuberculo-
sis and M. bovis are treated with antibiotics such as isoniazid,
ethambutol, rifampicin, and pyrazinamide in human beings
[6]. Treatment of infected animals is rarely attempted beca-
use of the high cost and prolonged time. Moreover it is con-
sidered illegal in some countries. M. avium, on the other
hand, is resistant to these antituberculosis drugs [2]. Due to
this fact and also because of the economical considerations,
treatment is not considered a viable option, particularly in
poultry sector. However, in case of M. avium infection of
exotic pet birds or birds maintained in zoo aviaries, treat-
ment against M. avium has to be considered and therapy
duration can go up to 12–18 months. In avian therapeutics
related to mycobacterial infections, the major diﬃculty is
that the pharmacokinetics in birds for most of the antimyco-
bacterial drugs is unknown [6]. Also, the relative hydropho-
bicity of the mycobacterial cell wall acts as a barrier that
restricts the activity of many hydrophilic antibiotics like the
aminoglycosides, ﬂuoroquinolones, and macrolides [6]. Bes-
ides, the slow growth and intracellular location of mycobac-
teria necessitate the need for extended periods of therapy.
There are clinical reports documenting the apparent
successful treatment of parrots with mycobacterial infec-
tions, but no studies to date investigate the treatment of
mycobacterial infections in birds [6]. M. avium has been
reported to respond to trimethoprim-sulfamethoxazole, sul-
ﬁsoxazole, amikacin, gentamicin, and kanamycin, during in
vitro studies [76]. M. avium i n f e c t i o n si np e tb i r d sh a v e
been treated with isoniazid, rifampin, rifabutin, ethambutol,
clofazimine, ciproﬂoxacin, enroﬂoxacin, streptomycin, and
amikacin and successful therapy of M. genavense infections
with clarithromycin in humans has been reported [6].
The apparent eﬀectiveness of the newer macrolides like
clarithromycin and azithromycin against both M. avium
and M. genavense make them suitable for treating mycobac-
terial infections in birds. However, the initial therapeutic
regimen should include rifabutin and ethambutol, and
later azithromycin or clarithromycin can be administered
concurrently. Birds that respond poorly to therapy should
have either a ﬂuoroquinolone or an aminoglycoside added
to the regimen. An alternative or additional drug that may
prove useful, especially in birds with a marked inﬂammatory
response, would be clofazamine. All these drugs may be
curative at a total daily dose of 85 mg/kg for clarithromycin,
43mg/kg for azithromycin, 56mg/kg for rifabutin, 56 to
85mg/kg for ethambutol, and 6 to 12mg/kg for clofazamine
as per the reports of VanDerHeyden [6]. In another study, to
augment the potential of existing drugs, a mycobacteriolytic
preparation called “stazyme” has been developed from the
Staphylococcus strain Clavelis. Stazyme was able to break
the permeability barrier of M. avium isolates, signiﬁcantly
enhancing the activity of anti-tuberculous drugs like etham-
butol, rifampicin, and amikacin [77].8 Veterinary Medicine International
8. PreventiveMeasures
The eradication of M. avium infection is diﬃcult due to the
chronic carrier state and intermittent shedding of organisms
by the infected birds. Measures to eliminate disease and
establishing/maintaining TB-free ﬂock should be followed.
Gill and Blandy [78] and Dhama et al. [11, 79]d e s c r i b e d
measures like sacriﬁcing the aﬀected ﬂocks, abandoning the
equipments and housing materials, removal of litter and
contaminated soil, elimination of older ﬂocks, following
of strict biosecurity procedures besides regular monitoring
with tuberculin and agglutination tests. Stress is a key
factor as it causes an increase in the rate of shedding to
precipitate outbreaks. The best way to control this disease
is to remove infected ones and carriers and also to reduce
stress factors by improving the environmental parameters
[2,11].Preventionisbestdonebyminimizingovercrowding,
providing proper ventilation and supplementing adequate
amounts of vitamins and minerals in diet. In case of avian
TB in a farm, birds in other ﬂocks in the same farm
should be quarantined and tested at 6–12 week intervals.
Neither the tuberculin nor the agglutination tests can be
depended upon for the detection of every infected bird,
therefore, as long as one infected bird remains in a ﬂock,
dissemination of disease is possible. So entire ﬂock needs
to be depopulated and repopulation on noninfected soil
and fresh litter may be the best approach. Frequent removal
of fecal material is the single most important factor in
preventing transmission. Disinfection of the poultry houses
should be done frequently. The practice of managing poultry
in free-range system should not be followed. Provide proper
biosecurity measures to prevent unrestricted movement of
chickens, thus preventing exposure from previously infected
premises or from wild birds, pigs, and other mammals.
For exotic birds prevent contact with infected birds or the
premises and housing previously used by them. Monitoring
for infection and disposing of positive reactors should
be followed along with practicing all reasonable hygienic
precautions to prevent entry of the infection. During the
import of exotic or domestic birds, tuberculin testing must
be mandatory in order to identify the presence of M. avium
and the newly introduced birds should be quarantined
for a minimum of 2 months [2, 5]. The diﬃculty of
tuberculin testing of all chickens or even a majority of
ﬂocks makes it impossible to obtain exact data on the
incidenceofM.aviuminfectionsofchickens.Novaccinesare
available for use in birds. Experimental vaccines with killed
and/or live mycobacteria for protecting chickens against TB
have been evaluated. Satisfactory protection was obtained
when M. avium serovar 6 was given orally [5, 9, 11].
Combination of inactivated and live M. avium serovars
7 and 19 can also give protection to a limited extent.
Nucleic acid-based vaccines may also be experimentally
tried using M. avium genes that can generate proteins to
elicit cell mediated immunity in birds [80, 81]. Simple,
whole cell or lysate vaccines and combinations of vaccine
preparations were identiﬁed that led to high levels of
protection [82].
9.Mycobacterium avium:
The Zoonotic Implications
Mycobacterium avium subsp. avium (MAA) represent vet-
erinary and economic risks in birds (mainly poultry) as
well as mammals (pigs, etc.). Infected animals and their
products (mainly eggs) often come from small household
production and pose a risk for human health [83]. Exposure
of humans to infected birds with the MAA microorganism
may cause a zoonotic infection, particularly in those with
immunocompromised diseases such as HIV/AIDS [84]. In
addition, the situation worsens due to the spread of HIV
infection in developing countries [85]. Unlike M. tuber-
culosis, human beings are generally resistant to M. avium
infection but occasionally they can get infected. Human
pulmonarytuberculosisduetoaviantuberclebacillihasbeen
reported during the early 1940’s [86]. High incidence of
sensitivitytoaviantuberculininmanhasalsobeenidentiﬁed
[87, 88]. It is essential to bear in mind that M. avium,
M. intracellulare, and M. genavense are of public health
concern mostly in immunocompromised hosts. Infections of
humans and animals caused by this M. intracellulare agent
are expected to rise. The M. avium infection, seen in many
AIDS patients, is a progressive disease that is refractory to
treatment [65, 89–91]. This is especially true in cases of
exposure to large numbers of organisms [6]. In humans, M.
avium is capable of inducing localized primary lymphadeni-
tis, pulmonary disease, and a disseminated form of infection
particularly in case of immunosuppressed individuals or
patients under transplant therapy [4, 22, 92, 93]. M. avium
also causes local wound infections with swelling of regional
lymph nodes. In adults, the organism frequently aﬀects
the lungs, producing respiratory signs and in children, the
cervical lymph nodes are often involved. Eccles and Ptak
[93] reported that M. avium causes a serious disseminated
bacterial infection in up to 40% of patients with advanced
HIV infection. In AIDS patients, the main route for M.
avium infection is the gastrointestinal tract and M. avium is
naturally tolerant to the low pH that exists in stomach [94].
Thetransmissionoccurringviaaerosolsresultsinpulmonary
infections as the organism frequently aﬀects the lungs with
endobronchial lesions [95]. During the infection, M. avium
can be demonstrated in vivo in lymph nodes, bone marrow,
urine, and sputum [87, 91, 95, 96]. Primarily, the serotype-1
of M. avium subsp. avium has been isolated from such indi-
viduals, clearly pointing role of birds in acquiring infection
[4]. It should also noteworthy that M. avium is a pathogen
that infects several hosts including birds, humans, cattle, and
pigs[45,97,98].Theyarealsoencounteredinenvironmental
sources like soil and water, having considerable ability to
overcome adverse and competitive conditions thanks to a
major preprotein translocase subunit that is coded by secA
gene of the species [99].
During a study from 1953 to 1968, in cattle and swine of
Great Britain, 13% of the total tubercle bacilli were typed as
M. avium and in pig population it was an astonishing 81%.
This should be correlated with the ever increasing number
of recorded cases of tuberculosis in man caused by M. avium
[64, 100]. Contaminated food originating from pig or otherVeterinary Medicine International 9
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Figure 3: Salient features of avian tuberculosis.
livestock is identiﬁed as potential source of human infection.
M. avium can infect and cause disease in some domestic
mammals but lesions usually are localized and less severe.
When domestic farm animals are infected, particularly cattle
and pigs, tuberculous lesions are commonly found localized
to the head and intestinal lymph nodes [1, 101]. As reported
by some workers, M. avium isolates from swine represent
the major threat to human beings. The similarity of the
IS1245 RFLP patterns of the human and porcine isolates
indicates close genetic relatedness, suggesting that M. avium
is transmitted between pigs and humans [64, 102].
Regarding the therapeutics, M. avium is of special
concern because drug regimens commonly used for treating
tuberculosis in humans are not eﬀective [22]. M. avium
strains are notorious in being resistant to isoniazid, the most
popular anti-TB drug [103, 104]. However the infection
was found subsided when treated with azithromycin or
clarithromycin together with ethambutol [6, 105]. Further,
the M. avium isolates have been demonstrated to get
inhibited by suﬃcient concentrations of sulfamethoxazole
in serum [106]. Rifabutin prophylaxis may also help in
controlling the disseminated infection [93]. Dunne et al.
[107] suggested the use of azithromycin as a safe, eﬀective,
and convenient option during disseminated infection in
HIV-infected patients. As per the ﬁndings of Horgen et al.
[108], rifampin-clarithromycin and rifampin-amikacin are
the most potent two-drug combinations, while rifampin-
amikacin-clarithromycin has been identiﬁed as a potent
three-drug combination. Likewise, Saito et al. [109] sug-
gested the use of benzoxazinorifamycin in combination
with clofazimine to be highly eﬃcacious in the therapy of
M. avium infections. In case of infection with M. genavense,
clarithromycin is the better choice when compared to
azithromycin [6].
Besides therapeutic interventions, there have been
numerous attempts to check the M. avium isolates in both
environment and in host. Lin et al. [110] suggested that
copper-silver ionization of drinking water is a better option
for the eﬀective control of M. avium.D a v i de ta l . [111]
proposed the use of synthetic macrocyclic compounds as a
new family of compounds that are capable of acting against
M. avium infections. The use of recombinant cytokine
molecules for the eﬀective killing of M. avium especially
interleukin-4(IL-4)hasbeenwellstudied[112–114].Theuse
ofadjunctiveimmunomodulatorytherapybyusingrecombi-
nant granulocyte-macrophage colony-stimulating factor has
also been reported [115]. Salem et al. [116] reported that
by encapsulating antibiotics like amikacin, streptomycin,
ciproﬂoxacin, sparﬂoxacin, and clarithromycin, their eﬀect
against M. avium can be enhanced. Iron accumulation has
beensuggestedtocontributetoanincreaseofthesusceptibil-
ity to mycobacterial infections. Iron deprivation, by the use
of iron chelators, restricts M. avium growth and this oﬀers a
novel approach in controlling infections in man [117].
So it is considered prudent to keep infected birds away
from humans, particularly the elderly, and individuals with
poor immune status. Hence the handling of infected birds
in farms should be carried out with adequate care, and
manipulation of material from infected birds or open live
cultures of M. avium in laboratories must be performed with
appropriate biohazard containment [3]. Healthy individuals
with normally functioning immune system have a high10 Veterinary Medicine International
resistance to this infection. However, it is recommended to
take proper precautions and avoid contact or exposure to
infected birds or their carcasses.
Salient features of avian tuberculosis are presented in
Figure 3.
10. Conclusion andFuturePerspectives
Members of the Mycobacterium avium complex (MAC) are
ubiquitous bacteria that can be found in water, food, and
other environmental samples and are considered oppor-
tunistic pathogens for numerous animal species, mainly
birdsandpigs,aswellasforhumans.Infectionscausedbythe
MACareontheriseinbothhumanandveterinarymedicine.
Avian tuberculosis is an important disease which aﬀects
companion, captive exotic, wild, and domestic bird, and has
public health signiﬁcance too. The most signiﬁcant cause of
poultry disease is M. avium. In recent years, the incidence
of avian tuberculosis in domestic poultry have declined
due to introduction of novel poultry husbandry practices,
namely, maintaining one-age ﬂocks, all in-all outfarming
system; provision of better hygiene and sanitation; stringent
implementation of biosecurity practices. But the inevitable
occasional stress and production demands in the poultry
sector could create dynamics similar to those that occur in
immune-compromised individuals. Also, M. avium pose a
signiﬁcant threat in layer and breeder farms, where high age
groups are maintained. Unless eliminated from the domestic
birds, tuberculosis will remain an economic burden on the
swine industry too and the role of pigs in transmitting the
disease to humans has been well documented. Disseminated
form of infections with M. avium is seen in increasing
numbers in immunocompromised individuals. M. avium
subsp. avium may have wild birds as major reservoirs
that are responsible for its shedding into environment and
facilitating its spread for years. The diversity of strain
types indicates that infections are acquired not from a
single reservoir alone. This is in contrary to the belief that
existent infected birds are the primary sources of infection
through fecal contamination of the environment. Under
these perspectives more studies should be performed on
identifying avian reservoirs and environmental sources of
M. avium. RFLP analysis and multiplex PCR methods can
further discriminate between diﬀerent isolates, which is
particularly useful for epidemiological studies. Identiﬁcation
oftheMACmembersbasedoncultureexaminationfollowed
by biochemical testing, can take up to several weeks, as
opposed to molecular biology methods that provide fast
and accurate identiﬁcation to the species level, which is
important in diagnosis and treatment of avian tuberculosis.
Am e a n so fe ﬀectively discriminating among closely related
yet pathogenically diverse members of the MAC would
enable better diagnosis and treatment as well as further
our understanding of the epidemiology of these pathogens.
Moreover, viewing the importance, the advanced diagnostic
tools and novel prevention strategies that are employed
against M. tuberculosis and M. avium in man needs to be
standardized for M. avium infections in birds and animals
as well.
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